Analyst Ratings for Five Prime Therapeutics (FPRX) [Neutrals]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/9/2021 | Guggenheim | Michael Schmidt | Downgrade | Neutral (Buy) |
38.00 (N/A) |
37.76 (38.00) |
0.64% | Details |
3/5/2021 | Jefferies | Eun Yang | Downgrade | Hold (Buy) |
38.00 (N/A) |
21.26 (38.00) |
78.74% | Details |